Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences

SAN DIEGO,Calif.,and SUZHOU andSHANGHAI,China,Sept. 14,2022 -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"),a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer,today announced that the management team will participate in and attend one-on-one meetings at three investor conferences in September 2022 as follows:

Citi Hong Kong China Corporate Day – Virtual

One-on-one meetings: Tuesday,September 20,2022 – Wednesday,September 21,2022

Cantor Oncology,Hematology & HemeOnc Conference

Panel Presentation: Wednesday,September 28 at 4:15 p.m. ET

One-on-one meetings: Wednesday,September 28,2022

Location: New York,NY

Jefferies Cell & Genetic Medicine Summit

Fireside Chat: Friday,September 30 at 2:00 p.m. ET

One-on-one meetings: Friday,September 30,NY

A webcast of the fireside chat will be available on the News and Events section of Gracell's investor website. A replay of the webcast will be available for 30 days following the event.

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CARTTM technology module,Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies,including lengthy manufacturing time,suboptimal cell quality,high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell,please visit www.gracellbio.com and follow @GracellBio on LinkedIn.

Media contact

Marvin Tang

marvin.tang@gracellbio.com

Investor contact

Gracie Tong

gracie.tong@gracellbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-301623784.html